Chembio Diagnostics (CEMI -3.8%) slips after pricing a public offering of 1.2M shares at $5, a 2.9% discount to Wednesday's close. Net proceeds on the sale come to around $5.5M, for which the maker of diagnostic testing equipment maker plans to use the funds for business expansion and working capital. Prior to the offering, it's current float stood at about 8.09M shares. Craig-Hallum is the sole book-running manager.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs